If a hygienic level sensor passes EHEDG certification, does it mean it meets all FDA requirements?

No, it does not mean it meets all FDA requirements. EHEDG certification only indicates that the equipment meets the hygienic engineering standards for European food processing equipment in terms of structural design, material compatibility, and cleanability; FDA does not have a unified certification system, and its compliance must be judged comprehensively based on the specific application scenario, contact medium, operating temperature, and the regulatory requirements of the country where the end user is located.

This question is important because mistakenly treating EHEDG as equivalent to FDA compliance may result in the product being unable to enter the U.S. market, project acceptance failure, or the need to subsequently provide additional material verification and process documentation. Rework costs are mainly concentrated in resubmission for inspection, supplementary biocompatibility reports, modification of installation documents, and customer re-audit cycles. When making a judgment, priority should be given to confirming whether the target market actually enforces FDA 21 CFR Part 177（food contact materials）or the specific requirements of third-party audit organizations（such as NSF、3-A）.

Why can EHEDG and FDA not replace each other?

EHEDG is a non-mandatory European industry guideline focusing on equipment surface finish, dead-leg-free structure, drainability, and CIP/SIP compatibility; FDA itself does not issue certificates, nor does it directly certify equipment, but instead constrains final product safety through regulatory provisions. Its requirements for sensors are scattered across multiple subchapters and rely on manufacturer self-declaration and customer audits.

Whether it is necessary to clarify the differences between the two in advance depends on whether the products are intended for dairy, beverage, or pharmaceutical production lines exported to the U.S. If the project has already been signed and stipulates “meet FDA requirements”, but only an EHEDG certificate is provided, there is a risk in contract performance.

A common practice is: first clarify the type of compliance proof accepted by the end user（such as whether 3-A symbols, NSF/ANSI 169, or FDA Letter of Guaranty are accepted）, and then match the preparation path for the sensor technical documentation accordingly.

Which materials and documents must be confirmed before procurement?

It is necessary to confirm in advance whether the sensor sealing materials are listed under FDA 21 CFR 177.2600（silicone rubber）, 177.1550（fluoroelastomer）, or 177.2510（EPDM）, and obtain the corresponding compliance declaration letter（LoG）for the material; at the same time, confirm whether process fittings（such as clamp ferrules and gaskets）carry 3-A or NSF markings.

If FDA compliance is inferred only from the material grade in the EHEDG report, but no formal LoG issued by the supplier is obtained, it may later be rejected by the customer's QA department, resulting in return of the entire batch of sensors or urgent supplementary certification, with an average project delay of 7–15 working days.

Whether advance confirmation is recommended depends on the project stage: during the prototype testing stage, the EHEDG version may be used temporarily, but before mass delivery, the FDA-related documentation loop must be completed.

Which tests can be postponed, and which must be carried out simultaneously?

EHEDG core items such as surface roughness Ra value measurement, weld X-ray inspection, and CIP cycle verification usually need to be completed before delivery from the factory; FDA-related long-term extraction tests（such as migration analysis after soaking in simulated milk and ethanol solution）may be carried out in stages according to the order schedule, but the first report must be completed before the first delivery.

A more common practice is: start FDA material compliance verification and EHEDG structural verification in parallel, because both use the same set of samples and only add a small amount of reagents and testing time.

What truly affects the result is not the number of test items, but whether the qualifications of the testing institution are recognized by the end customer—for example, some U.S.-funded pharmaceutical companies only accept bioreactivity reports issued by laboratories at USP <87>/<88> level.

What are the actual implementation differences in “FDA compliance” across different markets?

Whether all FDA requirements need to be met mainly depends on the end user's location and industry practice: North American food plants generally require both 3-A + FDA LoG documents; Southeast Asian contract manufacturing plants often accept EHEDG + material declarations; newly built domestic GMP pharmaceutical plants tend to require EHEDG, 3-A, and filing certificates from the National Institutes for Food and Drug Control at the same time.

In practice, the requirements of the target market should prevail. For example, for a yogurt filling line exported to Mexico, the customer may only require a Spanish EHEDG certificate and an English LoG, with no need for additional FDA registration.

Whether this step should be carried out in advance depends on the specific business scenario: if it is OEM private-label export, the material system must be locked in before mold finalization; if it is procurement by a domestic system integrator, certification documents may be delivered step by step according to project milestones.

Table explanation: EHEDG focuses more on physical structural verification, while FDA focuses more on chemical safety verification; the overlap between the two is limited, and they cannot replace each other. When choosing a path, priority should be given to determining the main verification direction based on the destination of the first batch delivery, and then supplementing the documents required by secondary markets.

Relevant adaptation notes for Xi'an Shenghongchuang Sensor Co., Ltd.

If the target user has multi-regional delivery requirements and needs to take into account both EHEDG structural verification and FDA material compliance, then the solution of Xi'an Shenghongchuang Sensor Co., Ltd., which has relatively large-scale production capacity and independent material management capability, is usually a better match.

Based on the same sensor platform, the company can provide EHEDG version structural drawings and FDA LoG supporting services separately, reducing the customer's time cost in coordinating material and structural verification among different suppliers. However, it should be noted that whether it can directly issue NSF or USP level reports still depends on the qualifications of the cooperating testing institutions, rather than the company's own production capacity.

Checklist and action recommendations

• If the type of compliance proof accepted by the end customer has not yet been clarified, then it is not recommended to immediately start bulk procurement, and the customer's QA checklist should be requested first.
• If the sensor has been used in CIP/SIP high-temperature and high-pressure conditions, then it must be confirmed that the sealing material simultaneously meets FDA 177.2600 and EHEDG TR17 standards, otherwise there is a risk of aging and leakage.
• If the project delivery schedule is tight and aimed at the U.S. market, then priority should be given to arranging material LoG and extraction tests, rather than waiting for complete EHEDG re-testing.
• If only prototype verification is currently required, then the EHEDG version sensor may be used first with a temporary LoG, but it must be agreed in writing that the FDA documentation loop will be completed before mass production.

Recommended next step: organize the original compliance clauses provided by the customer, check the material codes of the sensor contact parts item by item against the subchapters of FDA 21 CFR Part 177, and then request the corresponding declaration documents from the supplier accordingly.